Zacks Research Issues Optimistic Outlook for PAHC Earnings

Phibro Animal Health Co. (NASDAQ:PAHC) – Stock analysts at Zacks Research lifted their Q3 2025 EPS estimates for shares of Phibro Animal Health in a research note issued to investors on Wednesday, February 19th. Zacks Research analyst R. Department now forecasts that the company will post earnings of $0.48 per share for the quarter, up from their previous forecast of $0.35. The consensus estimate for Phibro Animal Health’s current full-year earnings is $1.95 per share. Zacks Research also issued estimates for Phibro Animal Health’s FY2025 earnings at $1.87 EPS, Q3 2026 earnings at $0.49 EPS and Q1 2027 earnings at $0.47 EPS.

Other research analysts have also issued research reports about the company. StockNews.com lowered Phibro Animal Health from a “strong-buy” rating to a “buy” rating in a report on Thursday, February 6th. Barclays boosted their price target on shares of Phibro Animal Health from $20.00 to $22.00 and gave the stock an “underweight” rating in a research note on Monday, February 10th. Finally, Morgan Stanley upped their target price on shares of Phibro Animal Health from $20.00 to $25.00 and gave the stock an “equal weight” rating in a research note on Tuesday, December 17th. Two analysts have rated the stock with a sell rating, two have given a hold rating and one has assigned a buy rating to the stock. According to data from MarketBeat.com, Phibro Animal Health currently has an average rating of “Hold” and an average target price of $21.00.

Phibro Animal Health Stock Down 2.0 %

NASDAQ PAHC opened at $22.50 on Monday. Phibro Animal Health has a 52 week low of $11.98 and a 52 week high of $26.55. The company has a quick ratio of 1.37, a current ratio of 3.20 and a debt-to-equity ratio of 2.99. The business’s fifty day simple moving average is $22.21 and its 200-day simple moving average is $22.18. The firm has a market cap of $911.32 million, a PE ratio of 46.88, a P/E/G ratio of 0.45 and a beta of 0.52.

Phibro Animal Health (NASDAQ:PAHC) last announced its earnings results on Wednesday, February 5th. The company reported $0.54 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.40 by $0.14. Phibro Animal Health had a net margin of 1.75% and a return on equity of 25.35%.

Hedge Funds Weigh In On Phibro Animal Health

Hedge funds have recently added to or reduced their stakes in the stock. Vanguard Group Inc. grew its position in shares of Phibro Animal Health by 1.4% during the fourth quarter. Vanguard Group Inc. now owns 1,514,736 shares of the company’s stock worth $31,809,000 after acquiring an additional 20,604 shares during the last quarter. American Century Companies Inc. grew its position in shares of Phibro Animal Health by 18.0% during the fourth quarter. American Century Companies Inc. now owns 635,599 shares of the company’s stock worth $13,348,000 after acquiring an additional 96,787 shares during the last quarter. Nuveen Asset Management LLC grew its position in shares of Phibro Animal Health by 21.4% during the fourth quarter. Nuveen Asset Management LLC now owns 588,001 shares of the company’s stock worth $12,348,000 after acquiring an additional 103,618 shares during the last quarter. Renaissance Technologies LLC grew its position in shares of Phibro Animal Health by 1.9% during the fourth quarter. Renaissance Technologies LLC now owns 557,800 shares of the company’s stock worth $11,714,000 after acquiring an additional 10,600 shares during the last quarter. Finally, Geode Capital Management LLC grew its position in shares of Phibro Animal Health by 1.7% during the fourth quarter. Geode Capital Management LLC now owns 515,979 shares of the company’s stock worth $10,838,000 after acquiring an additional 8,510 shares during the last quarter. 99.34% of the stock is currently owned by hedge funds and other institutional investors.

Phibro Animal Health Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, March 26th. Shareholders of record on Wednesday, March 5th will be paid a $0.12 dividend. The ex-dividend date of this dividend is Wednesday, March 5th. This represents a $0.48 annualized dividend and a yield of 2.13%. Phibro Animal Health’s dividend payout ratio is currently 100.00%.

Phibro Animal Health Company Profile

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.